Article
TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.
Oncogene - 1 Apr 2022
Wang Caihong, Zhang Shaosen, Ma Boyuan, Fu Yan, Luo Yongzhang
Abstract excerpt
Mutant p53 (mtp53) can exert cancer-promoting activities via "gain-of-function", which has become a popular research target. Although lots of researchers focus on the tumor-suppressor role for p53, the regulation of mutant p53 remains unknown. Here, we report a mechanism by which mtp53 regulate the transcription of Rab coupling protein (RCP) to influence lung cancer behavior. First, we show that RCP is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
